{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:39:49Z","timestamp":1791884389402,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T00:00:00Z","timestamp":1498262400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s11748-017-0798-5","type":"journal-article","created":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T04:28:27Z","timestamp":1498278507000},"page":"622-626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Safety and effectiveness of tolvaptan for fluid management after pediatric cardiovascular surgery"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-8212","authenticated-orcid":false,"given":"Yuzo","family":"Katayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritsugu","family":"Shiono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Masuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshiro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,24]]},"reference":[{"issue":"Suppl 1","key":"798_CR1","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s10557-011-6350-4","volume":"25","author":"T Onogawa","year":"2011","unstructured":"Onogawa T, Sakamoto Y, Nakamura S, Nakayama S, Fujiki H, Yamamura Y. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure. Cardiovasc Drugs Ther. 2011;25(Suppl 1):S67\u201376.","journal-title":"Cardiovasc Drugs Ther"},{"key":"798_CR2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00246-012-0373-x","volume":"34","author":"T Murakami","year":"2013","unstructured":"Murakami T, Horibata Y, Morimoto Y, Tateno S, Kawasoe Y, Niwa K. Syndrome of inappropriate secretion of antidiuretic hormone associated with angiotensin-converting enzyme inhibitor administration. Pediatr Cardiol. 2013;34:1261\u20133.","journal-title":"Pediatr Cardiol"},{"key":"798_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S1047951112002272","volume":"24","author":"Y Horibata","year":"2014","unstructured":"Horibata Y, Murakami T, Niwa K. Effect of the oral vasopressin receptor antagonist tolvaptan on congestive cardiac failure in a child with restrictive cardiomyopathy. Cardiol Young. 2014;24:155\u20137.","journal-title":"Cardiol Young"},{"key":"798_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2015.12.003","volume":"205","author":"K Higashi","year":"2016","unstructured":"Higashi K, Murakami T, Ishikawa Y, Itoi T, Ohuchi H, Kodama Y, et al. Efficacy and safety of tolvaptan for pediatric patients with congestive heart failure. Multicenter survey in the working group of the Japanese Society of PEdiatric Circulation and Hemodynamics (J-SPECH). Int J Cardiol. 2016;205:37\u201342.","journal-title":"Int J Cardiol"},{"key":"798_CR5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"M Gheorghiade","year":"2007","unstructured":"Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators, et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007;297:1332\u201343.","journal-title":"JAMA"},{"key":"798_CR6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","volume":"371","author":"G Decaux","year":"2008","unstructured":"Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet. 2008;371:1624\u201332.","journal-title":"Lancet"},{"key":"798_CR7","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1253\/circj.CJ-66-0068","volume":"77","author":"JCS Joint Working Group","year":"2013","unstructured":"JCS Joint Working Group. Guidelines for treatment of acute heart failure (JCS 2011). Circ J. 2013;77:2157\u2013201.","journal-title":"Circ J"},{"key":"798_CR8","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00246-013-0671-y","volume":"34","author":"RB Regen","year":"2013","unstructured":"Regen RB, Gonzalez A, Zawodniak K, Leonard D, Quigley R, Barnes AP, et al. Tolvaptan increases serum sodium in pediatric patients with heart failure. Pediatr Cardiol. 2013;34:1463\u20138.","journal-title":"Pediatr Cardiol"},{"key":"798_CR9","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00595-015-1251-y","volume":"45","author":"H Nishi","year":"2015","unstructured":"Nishi H, Toda K, Miyagawa S, Yoshikawa Y, Fukushima S, Kawamura M, et al. Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial. Surg Today. 2015;45:1542\u201351.","journal-title":"Surg Today"},{"key":"798_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-016-0712-6","author":"T Kido","year":"2016","unstructured":"Kido T, Nishi H, Toda K, Ueno T, Kuratani T, Sakaki M, et al. Predictive factors for responders to tolvaptan in fluid management after cardiovascular surgery. Gen Thorac Cardiovasc Surg. 2016;. doi:\n                        10.1007\/s11748-016-0712-6\n                        \n                    .","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"798_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-016-1406-5","author":"M Yamada","year":"2016","unstructured":"Yamada M, Nishi H, Sekiya N, Horikawa K, Takahashi T, Sawa Y. The efficacy of tolvaptan in the perioperative management of chronic kidney disease patients undergoing open-heart surgery. Surg Today. 2016;. doi:\n                        10.1007\/s00595-016-1406-5\n                        \n                    .","journal-title":"Surg Today"},{"key":"798_CR12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2016.06.156","volume":"220","author":"K Matsuyama","year":"2016","unstructured":"Matsuyama K, Koizumi N, Nishibe T, Iwasaki T, Iwahasi T, Toguchi K, et al. Effects of short-term administration of tolvaptan after open heart surgery. Int J Cardiol. 2016;220:192\u20135.","journal-title":"Int J Cardiol"},{"key":"798_CR13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jjcc.2012.09.002","volume":"60","author":"K Watanabe","year":"2012","unstructured":"Watanabe K, Dohi K, Sugimoto T, Yamada T, Sato Y, Ichikawa K, et al. Short-term effects of low-dose tolvaptan on hemodynamic parameters in patients with chronic heart failure. J Cardiol. 2012;60:462\u20139.","journal-title":"J Cardiol"},{"key":"798_CR14","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1253\/circj.CJ-16-0216","volume":"80","author":"M Miura","year":"2016","unstructured":"Miura M, Sugimura K, Sakata Y, Miyata S, Tadaki S, Yamauchi T, et al. Prognostic impact of loop diuretics in patients with chronic heart failure\u2014effects of addition of renin\u2013angiotensin\u2013aldosterone system inhibitors and beta-blockers. Circ J. 2016;80:1396\u2013403.","journal-title":"Circ J"},{"key":"798_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5414\/CN108457","volume":"84","author":"N Tominaga","year":"2015","unstructured":"Tominaga N, Kida K, Matsumoto N, Akashi YJ, Miyake F, Kimura K, et al. Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics\/pharmacodynamics study. Clin Nephrol. 2015;84:29\u201338.","journal-title":"Clin Nephrol"},{"key":"798_CR16","first-page":"143-015-0372-0","volume":"10","author":"TS Kato","year":"2015","unstructured":"Kato TS, Ono S, Kajimoto K, Kuwaki K, Yamamoto T, Amano A. Early introduction of tolvaptan after cardiac surgery: a renal sparing strategy in the light of the renal resistive index measured by ultrasound. J Cardiothorac Surg. 2015;10:143-015-0372-0.","journal-title":"J Cardiothorac Surg."},{"key":"798_CR17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","volume":"105","author":"SS Gottlieb","year":"2002","unstructured":"Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002;105:1348\u201353.","journal-title":"Circulation"},{"key":"798_CR18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1253\/circj.CJ-66-0093","volume":"78","author":"K Kinugawa","year":"2014","unstructured":"Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K. Efficacy and safety of tolvaptan in heart failure patients with volume overload. Circ J. 2014;78:844\u201352.","journal-title":"Circ J"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11748-017-0798-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-017-0798-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-017-0798-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T13:35:44Z","timestamp":1509024944000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11748-017-0798-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,24]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1007\/s11748-017-0798-5","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"value":"1863-6705","type":"print"},{"value":"1863-6713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,24]]}}}